In atypical hemolytic uremic syndrome (aHUS), complement overactivation on endothelial surfaces, oftentimes caused by FH mutations, promotes thrombotic microangiopathy and consequently hemolytic anemia, thrombocytopenia, and acute and chronic renal failure (14). This evidence concerns the gene FH and atypical hemolytic-uremic syndrome.